More information about AMOEBA

Based in Lyon, France, Amoéba, listed on Euronext, Paris, develops and will commercialize* the biopesticide BIOMEBA. Today, BIOMEBA is the first and unique biopesticide classified as non-hazardous for human health and the environment**. It harnesses the biocidal properties of Willaertia magna . We are currently seeking authorisation to expand commercialisation of this product on two continents. In parallel, we are continuing to develop the very promising pipeline of applications for Willaertia magna. If you would like more information, please contact us. Rapid take-off since 2010, based on solid scientific and IP foundations Willaertia magna C2c.maky, a natural water-borne amoeba was discovered in the natural hot spring water at Aix les Bains by reserchers from Claude Bernard University, Lyon (CBUL). This amoeba was found to be a potent phagocytic predator against pathogenic bacteria known to thrive in industrial water environments, such as Legionella, Listeria and Pseudomonas . Amoeba was created in 2010 and acquired an exclusive license from CBUL to use the patented Willaertia magna technology. Under the guidance of its experienced President and co-founder, Fabrice PLASSON, Amoéba quickly built up a very capable industrial biotechnology team. Led by Amoéba's co-founder, Jacques BODENNEC , this team developed Willaertia magna into a powerful, cost effective, biological biocide product, offering unparalleled industrial water treatment potential. Our biopesticide BIOMEBA has undergone rigorous scientific assessment, with a demanding validation process including field tests with renowned industrial partners. It also successfully completed all the required regulatory toxicological and eco-toxicological tests. Amoéba achieved the goal of completing this whole process in a remarkably short period of time-frame.